82 related articles for article (PubMed ID: 10606166)
41. Enumeration of CD34+ hematopoietic stem and progenitor cells.
Sutherland DR; Keeney M; Gratama JW
Curr Protoc Cytom; 2003 Aug; Chapter 6():Unit 6.4. PubMed ID: 18770780
[TBL] [Abstract][Full Text] [Related]
42. [Indications and limitations of purified CD34-positive cell transplantation].
Kawano Y; Takagami Y
Rinsho Ketsueki; 1999 Jun; 40(6):459-63. PubMed ID: 10422278
[No Abstract] [Full Text] [Related]
43. Hematopoietic stem cells: are they CD34-positive or CD34-negative?
Nakauchi H
Nat Med; 1998 Sep; 4(9):1009-10. PubMed ID: 9734390
[No Abstract] [Full Text] [Related]
44. [Clinical analysis of 8 cases of refractory hematopoietic reconstitution after haploid hematopoietic stem cell transplantation treated with purified donor CD34-selected hematopoietic stem cells].
He Y; Ma R; Wang HF; Zhang YY; Lyu M; Mo XD; Yan CH; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ; Sun YQ
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1027-1031. PubMed ID: 38503527
[No Abstract] [Full Text] [Related]
45. Introduction: Focus on hematology. CD34(+) or CD34(-): does it really matter?
Goodell MA
Blood; 1999 Oct; 94(8):2545-7. PubMed ID: 10515855
[No Abstract] [Full Text] [Related]
46. The tortoise and the hare: slow and steady stem cells win the race.
Dvorak CC
Leuk Res; 2010 May; 34(5):572-3. PubMed ID: 19959228
[No Abstract] [Full Text] [Related]
47. Clarification on the use of CEPRATE Stem Cell Concentration System and CEPRATE T Cell Depletion System.
Mennig D; Van Eeckhoven E
Bone Marrow Transplant; 1998 Jun; 21(12):1288. PubMed ID: 9674869
[No Abstract] [Full Text] [Related]
48. High stem cell dose in haemopoietic transplantation: is it always beneficial?
Urbano-Ispizua A
Leukemia; 2003 Aug; 17(8):1467-9. PubMed ID: 12886233
[No Abstract] [Full Text] [Related]
49. Esmail D. Zanjani, Ph.D.. Interview by Vicki P. Glaser.
Zanjani ED
J Hematother Stem Cell Res; 2000 Apr; 9(2):129-32. PubMed ID: 10813525
[No Abstract] [Full Text] [Related]
50. Use of control cells to standardize enumeration of CD34+ stem cells.
Roth P; Maples J; Hall J; Dailey T
Ann N Y Acad Sci; 1995 Dec; 770():370-2. PubMed ID: 8597378
[No Abstract] [Full Text] [Related]
51. Biological individuality and the new frontiers of immunological tolerance in hematopoietic stem cell transplantation.
Burgio GR; Zecca M; Comoli P; Maccario R
Haematologica; 2010 Sep; 95(9):1447-51. PubMed ID: 20807985
[No Abstract] [Full Text] [Related]
52. CD34: structure, biology, and clinical utility.
Krause DS; Fackler MJ; Civin CI; May WS
Blood; 1996 Jan; 87(1):1-13. PubMed ID: 8547630
[No Abstract] [Full Text] [Related]
53. Isolation of hematopoietic stem cells from heparinized cadaveric multiple organ donors: potential clinical implications.
Marlicz W; Paczkowski M; Kijowski J; Machalinski B; Gontarewicz A; Paczkowska E; Zukowski M; Turkiewicz W; Bohatyrewicz R; Czajkowski Z; Ostrowski M; Ratajczak MZ
Transplant Proc; 1999 Aug; 31(5):2099-101. PubMed ID: 10455982
[No Abstract] [Full Text] [Related]
54. Process validation.
Preti RA
Cytotherapy; 1999; 1(6):481-3. PubMed ID: 20426548
[TBL] [Abstract][Full Text] [Related]
55. Role of microparticles as messengers enhancing stem cell activity after genetic engineering.
Liehn EA; Bucur O; Weber C
Circ Res; 2012 Jul; 111(3):265-7. PubMed ID: 22821904
[No Abstract] [Full Text] [Related]
56. Stem cells: Out for the count.
McCarthy N
Nat Rev Cancer; 2010 Nov; 10(11):742. PubMed ID: 21080596
[No Abstract] [Full Text] [Related]
57. Reduced Number and Activity of Circulating Endothelial Progenitor Cells in Acute Aortic Dissection and Its Relationship With IL-6 and IL-17.
Huang Z; Liu Z; Wang K; Ye Z; Xiong Y; Zhang B; Liao J; Zeng L; Zeng H; Liu G; Zhan H; Yang Z
Front Cardiovasc Med; 2021; 8():628462. PubMed ID: 33869300
[TBL] [Abstract][Full Text] [Related]
58. Tissue-engineered urinary conduits.
Kates M; Singh A; Matsui H; Steinberg GD; Smith ND; Schoenberg MP; Bivalacqua TJ
Curr Urol Rep; 2015 Mar; 16(3):8. PubMed ID: 25677229
[TBL] [Abstract][Full Text] [Related]
59. Tissue engineering for the oncologic urinary bladder.
Drewa T; Adamowicz J; Sharma A
Nat Rev Urol; 2012 Oct; 9(10):561-72. PubMed ID: 22907387
[TBL] [Abstract][Full Text] [Related]
60. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
Burt RK
Stem Cells; 1999; 17(6):373-6. PubMed ID: 10606166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
